# Genmab A/S (GMAB): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/gmab for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Genmab A/S, a biopharmaceutical company founded in 1999 and headquartered in Copenhagen, Denmark, specializes in the discovery and development of innovative antibody therapies primarily for treating cancer and various other serious illnesses. The company's commercialized portfolio includes several key products: DARZALEX (daratumumab), a human monoclonal antibody for multiple myeloma (MM), non-MM blood cancers, and AL amyloidosis; teprotumumab, indicated for thyroid eye disease; ofatumumab, another human monoclonal antibody used in chronic lymphocytic leukemia (CLL) and multiple sclerosis; A...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $43.79 USD |
| Market Cap | $26.93B |
| P/E (TTM) | 33.00 |
| EPS (TTM) | $1.33 |
| 52-Week Range | $23.62 – $44.34 |
| Dividend Yield (TTM) | — |

## Dividend

GMAB has no dividend payment history in our records.

## Frequently Asked Questions

### What does Genmab A/S do?

Genmab A/S (GMAB) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is GMAB's market cap?

Genmab A/S (GMAB) has a market capitalization of approximately $26.93 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does GMAB pay a dividend?

No, Genmab A/S (GMAB) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Has GMAB ever paid a dividend?

No. Dividend Data's records show no dividend payments from Genmab A/S (GMAB). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/gmab
- Dividend history & safety: https://www.dividenddata.com/stocks/gmab/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/gmab/earnings
- Financial statements: https://www.dividenddata.com/stocks/gmab/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/gmab/valuation
- Peer comparison: https://www.dividenddata.com/stocks/gmab/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.